Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells

This publication has 10 references indexed in Scilit:

• Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs
  Leukemia, 2002
• Sampling Tumor-Draining Lymph Nodes for Phenotypic and Functional Analysis of Dendritic Cells and T Cells
  The American Journal of Pathology, 2002
• Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
  Blood, 2001
• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL–transformed hematopoietic cell lines
  Blood, 2000
• Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
  The Lancet, 1999
• Cytokine enhancement of immunogenicity in chronic myeloid leukaemia
  Leukemia, 1997
• Origin, maturation and antigen presenting function of dendritic cells
  Current Opinion in Immunology, 1997
• Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasm indicates an association with clearance of viral infection: results of a prospective study
  International Journal of Cancer, 1996
• Treatment of chronic myeloid leukemia by marrow transplantation [editorial; comment] [see comments]
  Blood, 1993